Body Dysmorphic Disorder Training

Service Description

Professor Susan Rossell presents 12 hours of LIVE in-person online training in Understanding, diagnosing and treating Body Dysmorphic Disorder (BDD) | Zoom TIME: 9:00am - 4:00pm SUMMARY: This training provides a comprehensive understanding of BDD by exploring its definition, diagnostic criteria, prevalence, and demographic considerations. It will differentiate BDD from related conditions and highlight common co-morbidities. Attendees will learn to recognise the symptoms and characteristics of BDD for accurate diagnosis and evaluation across various healthcare settings, including general practice and cosmetic surgery. Treatment options will be covered, focusing on pharmacological interventions and psychotherapies, with a particular emphasis on the CBT approach. Through group discussions and role plays, participants will engage in building a multidisciplinary treatment plan for BDD, ensuring a collaborative approach to care. LEARNING OUTCOMES: • Understand what BDD is - definition and diagnostic criteria, prevalence rates, demographic considerations, the difference between BDD and related conditions, and the common co-morbidities. • Recognise symptoms and characteristics of BDD when diagnosing and conducting an initial evaluation. Includes the importance of recognising BDD in all healthcare settings (general practice, cosmetic surgery). • Overview of treatment and support, including pharmacological treatments and psychotherapies. • CBT approach for BDD, with group discussions and role plays. • Build a treatment plan for BDD, with emphasis on the multidisciplinary approach. PRESENTER: Susan is a Professor of Cognitive Neuropsychiatry and Director of Clinical Trials at Swinburne University; she is also Co-Chair of MAGNET - the Australian mental health clinical trial network. She trained at the University of Manchester and King’s College London in the UK, holding a lectureship at Oxford University prior to moving to Australia. Susan published 450+ peer-reviewed articles and book chapters. She sits on the National Institute of Mental Health International BDD Scientific Advisory Group and is the Secretary for the steering committee of International Consortium of Hallucination Research (ICHR). She is internationally recognised for her work on BDD. She has advanced knowledge, improved and transformed outcomes in relation to the diagnosis and treatment of BDD.